Medicus Pharma (NASDAQ:MDCX) Now Covered by Analysts at Maxim Group

Maxim Group began coverage on shares of Medicus Pharma (NASDAQ:MDCXFree Report) in a research note issued to investors on Tuesday,Benzinga reports. The firm issued a buy rating and a $10.00 price objective on the stock.

Medicus Pharma Stock Down 10.5 %

MDCX opened at $2.64 on Tuesday. Medicus Pharma has a fifty-two week low of $1.80 and a fifty-two week high of $6.00.

About Medicus Pharma

(Get Free Report)

Medicus Pharma Ltd is a biotech/life sciences company focused on accelerating the clinical development programs of novel and disruptive therapeutics assets. Medicus Pharma Ltd is based in Toronto, Ontario.

Read More

Receive News & Ratings for Medicus Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medicus Pharma and related companies with MarketBeat.com's FREE daily email newsletter.